Structures by: Cansız A.
Total: 20
4-Benzyl-3-(2-hydroxyphenyl)-1H-1,2,4-triazole-5(4H)-thione
C15H13N3O1S1
Acta Crystallographica Section E (2004) 60, 10 o1883-o1885
a=5.7387(5)Å b=23.842(3)Å c=10.3045(9)Å
α=90.00° β=104.655(7)° γ=90.00°
1-amino-5-benzoyl-4-phenylpyrimidin-2(1H)-one
C17H13N3O2
Acta Crystallographica Section E (2004) 60, 12 o2476-o2478
a=11.7547(11)Å b=16.6566(11)Å c=7.2986(6)Å
α=90.00° β=101.722(7)° γ=90.00°
3-Benzyl-4-(4-methylphenyl)-1H-1,2,4-triazole-5(4H)-thione
C16H15N3S
Acta Crystallographica Section E (2004) 60, 12 o2281-o2283
a=12.3833(12)Å b=7.2297(5)Å c=15.8926(15)Å
α=90° β=95.488(7)° γ=90°
4-Allyl-2-(morpholin-4-ylmethyl)-5-(pyridin-4-yl)-2,4-dihydro-3H-1,2,4- triazole-3-thione
C15H19N5OS
Acta Crystallographica Section E (2005) 61, 6 o1953-o1955
a=8.9387(7)Å b=9.1043(7)Å c=10.6069(8)Å
α=88.509(6)° β=85.498(6)° γ=80.661(6)°
5,5'-Pyridine-2,6-diylbis[4-ethyl-2,4-dihydro-1,2,4-triazole-3(2H)-thione]
C13H15N7S2
Acta Crystallographica Section E (2006) 62, 6 o2198-o2199
a=6.7330(6)Å b=18.4906(13)Å c=12.3576(12)Å
α=90.00° β=100.162(8)° γ=90.00°
4-(4-Chlorophenyl)-3-(furan-2-yl)-1H-1,2,4-triazole-5(4H)-thione
C12H8ClN3OS
Acta Crystallographica Section E (2004) 60, 3 o425-o427
a=8.524(5)Å b=8.640(5)Å c=9.307(5)Å
α=91.426(5)° β=90.250(5)° γ=116.059(5)°
3-Benzyl-4-(4-chlorophenyl)-1H-1,2,4-triazole-5(4H)-thione
C15H12ClN3S
Acta Crystallographica Section E (2004) 60, 4 o642-o644
a=9.181(5)Å b=17.803(5)Å c=9.231(5)Å
α=90° β=108.882(5)° γ=90°
3-(2-Hydroxyphenyl)-4-phenyl-1H-1,2,4-triazole-5(4H)-thione
C14H11N3OS
Acta Crystallographica Section E (2004) 60, 9 o1580-o1582
a=5.7333(4)Å b=19.1695(16)Å c=11.6547(8)Å
α=90.00° β=103.441(6)° γ=90.00°
5-Benzyl-4-phenyl-2,4-dihydro-1,2,4-triazole-3-thione
C15H13N3S
Acta Crystallographica Section E (2004) 60, 9 o1507-o1509
a=7.0467(5)Å b=17.6802(13)Å c=11.2725(7)Å
α=90° β=104.355(5)° γ=90°
4-Phenyl-3-(pyridin-4-yl)-1H-1,2,4-triazole-5(4H)-thione
C13H10N4S
Acta Crystallographica Section E (2005) 61, 3 o619-o621
a=11.2958(6)Å b=12.7480(8)Å c=17.5607(8)Å
α=90° β=90° γ=90°
4,4'-Dibenzyl-5,5'-(pyridine-2,6-diyl)bis(2,4-dihydro-3H-1,2,4-triazole- 3-thione)
C23H19N7S2
Acta Crystallographica Section E (2006) 62, 5 o1822-o1823
a=10.6469(7)Å b=10.8127(7)Å c=21.9501(13)Å
α=89.500(5)° β=89.496(5)° γ=61.774(5)°
5-Phenyl-1,3,4-thiadiazol-2-amine
C8H7N3S
Acta Crystallographica Section E (2004) 60, 5 o820-o821
a=10.604(5)Å b=7.922(5)Å c=11.116(5)Å
α=90° β=117.965(5)° γ=90°
5-Furan-2-yl-1,3,4-oxadiazole-2(3H)-thione
C6H4N2O2S
Acta Crystallographica Section E (2004) 60, 3 o322-o323
a=5.194(5)Å b=20.102(5)Å c=6.914(5)Å
α=90° β=102.573(5)° γ=90°
5-Furan-2-yl-4-p-tolyl-2,4-dihydro-1,2,4-triazole-3-thione
C13H11N3O1S1
Acta Crystallographica Section E (2004) 60, 8 o1405-o1407
a=8.5665(15)Å b=8.7759(16)Å c=9.5372(17)Å
α=91.796(15)° β=91.407(14)° γ=116.386(12)°
5-(2-Hydroxyphenyl)-4-(p-tolyl)-2,4-dihydro-1,2,4-triazole-3-thione
C15H13N3OS
Acta Crystallographica, Section E (2004) 60, 8 o1339-o1341
a=26.524(3)Å b=11.3288(18)Å c=9.2310(11)Å
α=90.00° β=104.643(9)° γ=90.00°
5-(2-Furyl)-4-(4-methoxyphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
C13H11N3O2S
Acta Crystallographica Section E (2004) 60, 12 o2368-o2370
a=7.0789(6)Å b=8.4650(6)Å c=21.4774(13)Å
α=90° β=96.492(5)° γ=90°
4-Ethyl-5-(2-hydroxyphenyl)-2H-1,2,4-triazole-3(4H)-thione
C10H11N3OS
Acta Crystallographica Section E (2005) 61, 1 o17-o19
a=9.7879(8)Å b=7.9071(5)Å c=13.8045(10)Å
α=90.00° β=102.266(6)° γ=90.00°
4-Amino-5-(2-hydroxyphenyl)-2H-1,2,4-triazole-3(4H)-thione
C8H8N4OS
Acta Crystallographica Section E (2005) 61, 10 o3214-o3216
a=12.0231(19)Å b=5.7685(8)Å c=14.434(2)Å
α=90° β=114.393(11)° γ=90°
3,3'-(Pyridine-2,6-diyl)bis(4-allyl-4,5-dihydro-1H-1,2,4-triazole-5-thione)
C15H15N7S2
Acta Crystallographica Section E (2006) 62, 10 o4385-o4387
a=10.0527(7)Å b=10.7295(7)Å c=16.5864(12)Å
α=73.027(5)° β=88.204(6)° γ=89.503(6)°
6-Phenyl-3-(4-pyridyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole
C14H9N5S
Acta Crystallographica Section C (2005) 61, 11 o665-o667
a=11.3331(9)Å b=5.4092(3)Å c=20.3509(18)Å
α=90.00° β=90.653(7)° γ=90.00°